Executive Succession Planning for Swiss Oncology Biotechnology

We delivered market insights and a VP Finance shortlist, supporting a Swiss oncology biotech’s IPO plans.

The Challenge

A Swiss oncology biotech engaged Barrington James Board and Executive Partners to support their succession planning and strategic decision-making. Exploring several future pathways, including a potential Nasdaq IPO, they sought a market mapping exercise to identify and profile experienced Vice Presidents (VPs) of Finance who had successfully led oncology biotechs through similar transitions. The focus was on talent within Switzerland and the United States.

Objective

The project aimed to provide deep market insights into candidates capable of navigating the complexities of an IPO. We analysed key metrics such as gender distribution, typical job titles and hierarchies, and compensation trends for senior finance professionals in the clinical-stage oncology biotech sector. This intelligence was designed to support the client in evaluating the leadership landscape and aligning with their growth ambitions.

Outcome

Barrington James delivered a tailored solution that included a curated list of high-potential candidates alongside actionable market intelligence. This comprehensive resource enabled the client to confidently assess their leadership options and prepare for the next phase of their growth, whether that meant advancing towards a Nasdaq listing or exploring alternative strategic opportunities.

Discover the Power of Our Executive Search Solutions

Are you preparing for a Nasdaq listing or refining your executive leadership team? Partner with Barrington James Board and Executive Partners for bespoke market insights and talent solutions that drive strategic success.